StockData
ProKidney Corp. logo

ProKidney Corp. (PROK) stock

PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.04−0.00 (-0.48%)

Close on Nov 16, 2026Market cap $314.42MP/E –Yield –

ProKidney profit margin

Profit margin (net margin) is net income as a percentage of revenue.

ProKidney's profit margin for the twelve months ending Jun 30, 2026 was -10288.4%. For fiscal 2025 it was -7725.2%, against -80507.9% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-7725.2%+72782.7
FY2024Dec 31, 2024-80507.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-18948.0%−11458.4
Q1 FY2026Mar 31, 2026-8865.9%−1590.3
Q4 FY2025Dec 31, 2025-8547.1%+19450.3
Q3 FY2025Sep 30, 2025-7589.4%–
Q2 FY2025Jun 30, 2025-7489.6%–
Q1 FY2025Mar 31, 2025-7275.7%–
Q4 FY2024Dec 31, 2024-27997.4%–

More ProKidney figures

See a number that looks wrong?